Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10543728rdf:typepubmed:Citationlld:pubmed
pubmed-article:10543728lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C0013935lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C0085828lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C0016030lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C1510411lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C1709313lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C1148673lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C0486616lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C2266866lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C0205349lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:10543728lifeskim:mentionsumls-concept:C0596448lld:lifeskim
pubmed-article:10543728pubmed:issue1lld:pubmed
pubmed-article:10543728pubmed:dateCreated1999-11-22lld:pubmed
pubmed-article:10543728pubmed:abstractTextTranscription factors of the AP-1/ATF family, including c-Fos, c-Jun, and ATF-2, play an important role in the regulation of cell proliferation and differentiation, and changes in their levels and/or activities may contribute to oncogenesis. We analyzed the alterations of AP-1/ATF transcription factors upon immortalization and transformation in a panel of cell lines derived from rat embryo fibroblast (REF) cells. The tumorigenic E1A + cHa-ras cells are characterized by high and constitutive DNA binding activities of AP-1, in contrast to nontransformed cells and the E1A cells. The expression of c-fos and c-jun genes was affected differently by the oncogenic transformation. By using antibodies to c-Jun and c-Fos proteins in electrophoretic mobility shift assays (EMSA), we showed that E1A + cHa-ras transformants did not contain c-Fos under any condition of cell cultivation and growth factor stimulation, whereas c-Jun was constitutively upregulated. In the absence of c-fos gene expression, c-Fos protein appears to be replaced by proteins of Fos family (Fra-1) and ATF family (ATF-2 and ATFa). To determine the possible mechanisms of c-fos downregulation in E1A + cHa-ras transformants we have obtained populations of geneticin-resistant clones containing integrated reporter construct -711fos-CAT and its mutants in serum-responsive element (SRE) and cAMP-responsive element (CRE). Data obtained show that the mutations within the SRE lead to a manifold activation of fos-CAT expression. This allows to suggest that c-fos downregulation in E1A + cHa-ras transformants is provided by a negative control mediated through the SRE regulatory region. The profound differences in regulation and composition of transcription factors of the AP-1 family probably play a pivotal role in the transformation of REF cells by E1A and cHa-ras oncogenes.lld:pubmed
pubmed-article:10543728pubmed:languageenglld:pubmed
pubmed-article:10543728pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10543728pubmed:citationSubsetIMlld:pubmed
pubmed-article:10543728pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10543728pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10543728pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10543728pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10543728pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10543728pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10543728pubmed:statusMEDLINElld:pubmed
pubmed-article:10543728pubmed:issn1052-2166lld:pubmed
pubmed-article:10543728pubmed:authorpubmed-author:van der EbA...lld:pubmed
pubmed-article:10543728pubmed:authorpubmed-author:PospelovV AVAlld:pubmed
pubmed-article:10543728pubmed:authorpubmed-author:SvetlikovaS...lld:pubmed
pubmed-article:10543728pubmed:authorpubmed-author:MedvedevA VAVlld:pubmed
pubmed-article:10543728pubmed:authorpubmed-author:PospelovaT...lld:pubmed
pubmed-article:10543728pubmed:authorpubmed-author:KukushkinA...lld:pubmed
pubmed-article:10543728pubmed:authorpubmed-author:DorsmanJ CJClld:pubmed
pubmed-article:10543728pubmed:issnTypePrintlld:pubmed
pubmed-article:10543728pubmed:volume8lld:pubmed
pubmed-article:10543728pubmed:ownerNLMlld:pubmed
pubmed-article:10543728pubmed:authorsCompleteYlld:pubmed
pubmed-article:10543728pubmed:pagination19-32lld:pubmed
pubmed-article:10543728pubmed:dateRevised2009-12-17lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:meshHeadingpubmed-meshheading:10543728...lld:pubmed
pubmed-article:10543728pubmed:year1999lld:pubmed
pubmed-article:10543728pubmed:articleTitleE1A + cHa-ras transformed rat embryo fibroblast cells are characterized by high and constitutive DNA binding activities of AP-1 dimers with significantly altered composition.lld:pubmed
pubmed-article:10543728pubmed:affiliationInstitute of Cytology, Russian Academy of Sciences, St-Petersburg.lld:pubmed
pubmed-article:10543728pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10543728pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10543728lld:pubmed